These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7623920)

  • 1. Methotrexate for Crohn's disease.
    Korelitz BI; Present DH
    N Engl J Med; 1995 Aug; 333(9):600-1. PubMed ID: 7623920
    [No Abstract]   [Full Text] [Related]  

  • 2. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Terdiman JP; Gruss CB; Heidelbaugh JJ; Sultan S; Falck-Ytter YT;
    Gastroenterology; 2013 Dec; 145(6):1459-63. PubMed ID: 24267474
    [No Abstract]   [Full Text] [Related]  

  • 3. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Dassopoulos T; Sultan S; Falck-Ytter YT; Inadomi JM; Hanauer SB
    Gastroenterology; 2013 Dec; 145(6):1464-78.e1-5. PubMed ID: 24267475
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive drugs in Crohn's disease.
    Kornbluth A; George J; Sachar DB
    Gastroenterologist; 1994 Sep; 2(3):239-46. PubMed ID: 7987622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Crohn's disease].
    Vavricka SR; Rogler G
    Praxis (Bern 1994); 2009 Jan; 98(2):77-81. PubMed ID: 19153955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The debated role for thiopurines in Crohn's disease.
    Herrlinger KR; Stange EF
    J Crohns Colitis; 2014 Feb; 8(2):172-4. PubMed ID: 24342765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronically active Crohn's disease].
    Hoffmann J; Zeitz M;
    Z Gastroenterol; 2003 Jan; 41(1):31-5. PubMed ID: 12541171
    [No Abstract]   [Full Text] [Related]  

  • 8. How effective are the usual treatments for Crohn's disease?
    Bebb JR; Scott BB
    Aliment Pharmacol Ther; 2004 Jul; 20(2):151-9. PubMed ID: 15233694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive treatment and Crohn's disease].
    Delwaide J; Louis E; Gast P; Belaiche J
    Rev Med Liege; 1991 Jan; 46(1):22-8. PubMed ID: 2011678
    [No Abstract]   [Full Text] [Related]  

  • 11. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
    Korelitz BI; Present DH
    J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine and 6-mercaptopurine for Crohn's disease.
    Lancet; 1980 Aug; 2(8189):298-9. PubMed ID: 6105443
    [No Abstract]   [Full Text] [Related]  

  • 13. How should we treat Crohn's disease?
    Sleisenger MH
    N Engl J Med; 1980 May; 302(18):1024-6. PubMed ID: 6102738
    [No Abstract]   [Full Text] [Related]  

  • 14. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
    N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease.
    Boyle B; Mackner L; Ross C; Moses J; Kumar S; Crandall W
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):714-7. PubMed ID: 20706154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.